Search
SOLACI Congress
HomeCONGRESS

CONGRESS

View Category
Day 2

BIOSCIENCE study: Absorbable polymer versus permanent in sirolimus-eluting stents

This multicenter study randomized 1063 patients to receive the sirolimus-eluting stent with absorbable polymer and 1056 patients...
solaci -
Learn More
Day 2

ANTHEM-HF: autonomic regulation to improve ventricular function

In the context of heart failure, there is an autonomic imbalance characterized by increased sympathetic activity and...
solaci -
Learn More
Day 1

LISTEN: Rosuvastatin versus atorvastatin in Japanese diabetic patients

The treatment of hyperlipidemia is useful in primary and secondary prevention of chronic heart disease and stroke,...
solaci -
Learn More
Day 1

COPPS-2: Colchicine for prevention of post-pericardiotomy syndrome and postoperative atrial fibrillation

180 patients with colchicine 0.5 mg twice daily from 48-72 hs. before surgery versus 180 patients to...
solaci -
Learn More
Day 1

ODYSSEY FH I and FH II: Alirocumab in patients with heterozygous familial hypercholesterolemia

The study included patients with a diagnosis of heterozygous familial hypercholesterolemia who were receiving the maximum tolerated...
solaci -
Learn More
Day 1

SIGNIFY: Ivabradine does not reduce events in patients with stable coronary disease

The increase in heart rate in the setting of chronic coronary artery disease is associated with poor...
solaci -
Learn More
Day 1

ODYSSEYCOMBO II: Alirocumab more effective than ezetimibe when statins are insufficient

The aim of the study was to show a reduction in LDL cholesterol with the use of...
solaci -
Learn More
Day 1

SOLID-TIMI 52: Darapladib to reduce new cardiovascular events after myocardial infarction

This study randomized 1: 1 patient who had been hospitalized for acute coronary syndrome within 30 days...
solaci -
Learn More

SOLACI is the reference organization for Latin American cardiovascular interventionism.

Last News

Valve-in-Valve in Small Surgical Aortic Bioprostheses: Balloon-Expandable or Self-Expanding? Three-Year Results from the LYTEN Trial

Dr. Juan Manuel Pérez - 0
Dysfunction of small surgical aortic bioprostheses represents a challenging scenario for transcatheter aortic valve replacement in the valve-in-valve setting, due to the higher incidence...

AHA/ACC Guideline on the Management of Acute Pulmonary Embolism 2026

Dr. Omar Tupayachi - 0
The 2026 ACC/AHA guideline for the management of acute pulmonary embolism (PE) introduces a conceptual shift by replacing the traditional “risk-based” classification with an...

How real are the adverse effects of statins? Evidence from randomized clinical trials

Dr. Juan Manuel Pérez - 0
The safety of statins continues to be a subject of debate, partly due to the extensive list of adverse effects included in prescribing information,...

Institutional News

Fellow’s Corner 2026 – Submit Your Clinical Case

solaci - 0
Share your experience. Learn from experts. Grow as an interventional cardiologist. The Latin American Society of Interventional Cardiology (SOLACI) is relaunching this year the Fellow’s...

Watch Again: Cardiovascular Risk Factors in Women | SOLACI Technicians Webinar

solaci - 0
The webinar “Cardiovascular Risk Factors in Women,” held on January 27, 2026, via the Zoom platform, is now available for viewing on SOLACI’s YouTube...

Technical Training in Hemodynamics and Interventional Cardioangiology | SOLACI–CACI

solaci - 0
The SOLACI–CACI Technical Training in Hemodynamics and Interventional Cardioangiology is an academic program designed for the initial training and professional development of non-physician healthcare...

Access

Adolfo Alsina 2653 · Piso 2H · CABA · Buenos Aires · Argentina · (5411) 4954 7173 · info@solaci.org · solaci.org · Terms of Use -Privacy Policy